.webp)
We’re thrilled to announce that Semble has secured a £30 million Series C funding round led by European growth investor Revaia, with participation from a second new investor Partech, alongside continued backing from existing investors Mercia Ventures and Octopus Ventures.
Founded to address the lack of coordination in healthcare, Semble is one of Europe’s fastest-growing clinical platforms, helping outpatient providers coordinate care and manage the entire patient journey. We’re redefining the healthcare operating model through care orchestration and today, more than 10 million patients - around 1 in 6 people in the UK - have received care from a clinician using our platform.
The investment comes as healthcare providers across the UK and Europe face mounting operational pressure caused by fragmented technology systems, rising patient demand and a generational shift towards private medical insurance and self-pay care models.
As one of the most widely adopted systems for managing private healthcare in the UK, the funding will drive our expansion into the largest healthcare groups, advance our position as the AI orchestration layer underpinning modern care delivery, and cement our position in France, where our open, flexible platform has demonstrated significant regulatory maturity in less than a year.
Christoph Lippuner, CEO and co-founder of Semble, said: “For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients.
He added: “What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.”
Semble was named by TIME as one of the World's Top HealthTech Companies for 2025, and we are increasingly cementing our position as the default operating layer for private outpatient hospitals and enterprise healthcare groups, seeing strong momentum among those seeking to consolidate fragmented operational systems into unified platforms. Our 1,700 customers include some of the UK's most recognised healthcare brands including Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality and ProblemShared.
Morgan Kessous, Partner at Revaia, which leads the Series C round, said: "Semble is building the system of action for modern healthcare - a platform with genuine clinical depth, real scale and the trust of healthcare providers across the UK and France. The European healthcare market is being reshaped - by technology, by demand and by shifting patient expectations - and Semble is exceptionally well positioned to lead it. Revaia is proud to back the company with the investment further strengthening its conviction in the long-term transformation of healthcare."
In addition to increasing our headcount by over 50% since December 2024, we have also expanded our partnerships and integrations ecosystem to over 1,200 external tools, as healthcare providers increasingly seek interoperable infrastructure.
We plan to use the funding to further our ambition of becoming the AI care orchestration layer underpinning modern healthcare delivery across Europe.
.webp)
